等待開盤 09-20 09:30:00 美东时间
-0.100
-3.25%
BioCardia (NASDAQ:BCDA) said the company has regained full compliance with the Nasdaq Capital Market’s listing requirements. Press Release More on BioCardia BioCardia, Inc. (BCDA) Q2 2024 Earnings Cal...
09-18 20:35
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Seeking Alpha's earnings calendar for a full list of companies due to report....
09-14 03:00
BioCardia's (NYSE:BCDA) short percent of float has risen 71.29% since its last ...
09-05 01:00
Ensysce Biosciences shares are trading lower by 30% during Thursday's session. The company announced a $5 million registered direct offering and concurrent private placement.
08-29 23:10
BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA Steerable Introducer product family.
08-29 21:28
BCDA: 162% | BioCardia shares are trading higher after FDA cleared the company to market its Morph DNA Steerable Introducer product family. LUCY: 72% | Innovative Eyewear shares are trading higher after
08-29 20:24
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
08-22 21:20
BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results
08-14 04:30
BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.88) per share. The com...
08-14 04:05
This product family is intended to provide a pathway through which medical instruments, such as balloon dilatation catheters, guidewires, or other therapeutic devices, may be introduced into the peripheral vasculature or
07-30 19:09